Expression of CD137 and CD137 ligand in colorectal cancer patients

Oncology Reports

Volumn 15, Issue 5, 2006, Pages 1197-1200

  Dimberg, Jan ^a   Hugander, Anders ^b   Wågs̈ater, Dick ^c  

^a JÖNKÖPING UNIVERSITY   (Sweden)

^b RYHOV COUNTY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

CD137; CD137L; Colorectal cancer; Cytokines; Protein expression

Indexed keywords

CD137 ANTIGEN; CD137 LIGAND; LEUKOCYTE ANTIGEN; NERVE GROWTH FACTOR RECEPTOR; TNFRSF9 PROTEIN, HUMAN; TNFSF9 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CELL CULTURE; COLON; COLON TUMOR; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; RECTUM; RECTUM TUMOR;

4-1BB LIGAND; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD137; COLON; COLONIC NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; RECTAL NEOPLASMS; RECTUM; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTORS;

EID: 33744989961     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.5.1197     Document Type: Article

References (21)

1. Balkwill F and Mantovani A: Inflammation and cancer: back to Virchow? Lancet 357: 539-545, 2001. (Pubitemid 32173595)
2. Coussens LM and Werb Z: Inflammation and cancer. Nature 420: 860-867, 2002. (Pubitemid 36019639)
3. Pollok KE, Kim SH and Kwon BS: Regulation of 4-1BB expression by cell-cell interactions and the cytokines, interleukin-2 and interleukin-4. Eur J Immunol 25: 488-494, 1995.
4. Langstein J, Michel J, Fritsche J, Kreutz M, Andreesen R and Scwarz H: CD137 (ILA/4-1BB), a member of the TNF receptor family regulates monocyte activation via bidirectional signaling. J Immunol 160: 2488-2492, 1998.
5. Boussaud V, Soler P, Moreau J, Goodwin RG and Hance AJ: Expression of three members of the TNF-R family of receptors (4-1BB, lymphotoxin-beta receptor and Fas) in human lung. Eur Respir J 12: 926-931, 1998. (Pubitemid 28491669)
6. Broll K, Richter G, Pauly S, Hofstaedter F and Schwarz H: CD137 expression in tumor vessel walls. High concentration with malignant tumors. Am J Clin Pathol 115: 543-549, 2001. (Pubitemid 32275946)
7. Seko Y, Sugishita K, Sato O, Takagi A, Tada Y, Matsuo H, Yagita H, Okumura K and Nagai R: Expression of costimulatory molecules (4-1BBL and Fas) and major histocompatibility class I chain-related A (MICA) in aortic tissue and Takayasu's arteritis. J Vasc Res 41: 84-90, 2004. (Pubitemid 38296303)
8. Cannons JL, Hoeflich KP, Woodgett JR and Watts TH: Role of the stress kinase pathway in signaling via the T cell costimulatory receptor 4-1BB. J Immunol 163: 2990-2998, 1999. (Pubitemid 29431793)
9. Salih HR, Schmetzer HM, Burke C, Starling GC, Dunn R, Pelka-Fleischer R, Nuessler V and Kiener PA: Soluble CD137 (4-1BB) ligand is released following leukocyte activation and is found in sera of patients with hematological malignancies. J Immunol 167: 4059-4066, 2001. (Pubitemid 32910853)
10. Pollok KE, Kim Y-J, Hurtado JC, Zhou Z, Kim KK and Kwon BS: 4-1BB T cell antigen binds to mature B cells and macrophages and co-stimulates anti-μ primed splenic B cells. Eur J Immunol 24: 367-374, 1994. (Pubitemid 24041126)
11. Salih HR, Kosowski SG, Haluska VF, Starling GC, Loo DT, Lee F, Aruffo AA, Trail PA and Kiener PA: Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells. J Immunol 165: 2903-2910, 2000. (Pubitemid 30660743)
12. Balkwill F: Chemokine biology in cancer. Semin Immunol 15: 49-55, 2003.
13. Baier PK, Eggstein S, Wolff-Vorbeck G, Baumgartner U and Hopt UT: Chemokines in human colorectal carcinoma. Anticancer Res 25: 3581-3584, 2005. (Pubitemid 41105244)
14. Bollag DM, Rozycki MD and Edelstein SJ: Protein Methods. Wiley-Liss, New York, 1996.
15. DeBenedette MA, Shahinian A, Mak TW and Watts TH: Co-stimulation of CD28-T lymphocytes by 4-1BB ligand. J Immunol 158: 551-559, 1997. (Pubitemid 127492629)
16. Michel J, Pauly S, Langstein J, Krammer PH and Schwarz H: CD137-induced apoptosis is independent of CD95. Immunology 98: 42-46, 1999. (Pubitemid 29425907)
17. Kienzle G and von Kempis J: CD137 (ILA/4-1BB) expressed by primary human monocytes induces monocyte activation and apoptosis of B lymphocytes. Int Immunol 12: 73-82, 2000. (Pubitemid 30045414)
18. Konishi K, Fujii N, Boku S, Kato I, Ohtsu A, Tajiri H, Ochiai A and Yoshida S: Clinicopathological differences between colonic and rectal carcinomas: are they based on the same mechanism of carcinogenesis? Gut 45: 818-821, 1999.
19. Jung HW, Choi SW, Choi JI and Kwon BS: Serum concentrations of soluble 4-1BB and 4-1BB ligand correlated with the disease severity in rheumatoid arthritis. Exp Mol Med 36: 13-22, 2004. (Pubitemid 38379632)
20. Michel J and Schwarz H: Expression of soluble cd137 correlates with activation-induced cell death of lymphocytes. Cytokine 12: 742-746, 2000. (Pubitemid 30453509)
21. Furtner M, Straub RH, Kruger S and Schwarz H: Levels of soluble CD137 are enhanced in sera of leukemia and lymphoma patients and are strongly associated with chronic lymphocytic leukemia Leukemia 19: 883-885, 2005. (Pubitemid 40663117)